![]()
INVENTIVE & NOVEL APPROACHES FOR THE DESIGN OF CLINICAL TRIALS
- Novel Design for Early Stage Trials in Oncology
- Innovative Clinical Trial Design in Oncology = panacea and/or pitfall ?
- Adaptive Clinical Trial Design in Oncology
- Proof-of-Concept Approaches in Oncology Clinical Development
- Cancer Clinical Trials: Assessing the Time – Dependent Effects of Adjuvant Therapy
USE OF BIOMARKERS IN ONCOLOGY CLINICAL TRIAL DEVELOPMENT
- Biomarker-driven drug development in Oncology: challenges that change paragisms
- Biomarker-Driven Decision Making
- Biomarker Strategies to Develop Novel Cancer Therapeutics
- Breast Cancer Clinical Trials in Developing Countries
- Phase 1; Critical Moment in Clinical Drug Development
- Novel Cytotoxics in the World of Changing Paradigms: Case study of palifosfaminade
- Define the terms: “Expand Access Programs”: Threatment Protocol, Named Patient Program
CLINICAL TRIALS IN RARE DISEASES
- Clinical Trials in Rare Diseases
REGULATORY CHALLENGES SURROUNDING CLINICAL TRIAL DESIGN
- Optimizing Design In Paediatric Regulatory Studies
IMPROVING CLINICAL TRIAL DEVELOPMENT
- Are we Efficient in Drug Development?
- Use of Mobile Technologies to Improve Clinical Trial Compliance



